Pharmaceutical Executive July 9, 2024
Executives in the life sciences and medical device industries see promise in artificial intelligence (AI) and medical technologies, but must also navigate the changing healthcare ecosystem, varied stakeholder needs, and the impact of AI on market access and commercialization strategies.
Recently, more than 4,000 people from across the globe gathered in Atlanta to address the latest methodologies, data analytics, and evidence-based approaches that drive transformative change. The conference was held by ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR). One organization in attendance was Avalere Health, a global commercialization firm that partners with stakeholders across the healthcare ecosystem to provide a variety of services, including market access and HEOR. The following is Avalere Health’s global CEO’s perspective on...
Today's Sponsors
Today's Sponsor